Nicole Nelson
Physician Assistant · Salt Lake City, UTNPI 1508525411
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.5% of the total across 329 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 21.9% — the pattern of someone who eats at a lot of different presentations. Among physician assistant clinicians in UT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 329 payments — averaging $21.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$956
- Johnson & Johnson$724
- Bristol Myers Squibb$468
- Intra-sana Laboratories$372
- Takeda Pharmaceuticals U.S.A., Inc.$316
- plus $3K from 22 others
What the payments were for
- Food & beverage$6,65895%
- Education$1172%
- Gifts$2003%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 72 | $1,525 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 60 | $956 |
| Johnson & Johnson | 28 | $724 |
| Bristol Myers Squibb | 27 | $468 |
| Intra-sana Laboratories | 5 | $372 |
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $316 |
| Gilead | 10 | $273 |
| Sanofi | 15 | $271 |
| Ardelyx, Inc. | 11 | $248 |
| Aimmune Therapeutics, Inc. | 12 | $245 |
| Pfizer | 11 | $182 |
| QOL Medical, LLC | 7 | $181 |
| Redhill Biopharma Inc. | 7 | $165 |
| Regeneron Healthcare Solutions, Inc. | 8 | $140 |
| Merck | 9 | $138 |
| E.r. Squibb & Sons, L.L.C. | 1 | $124 |
| Phathom Pharmaceuticals, Inc. | 5 | $100 |
| Lilly USA, LLC | 4 | $87 |
| Celltrion USA Inc. | 4 | $70 |
| Ironwood Pharmaceuticals, Inc | 4 | $67 |
| Madrigal Pharmaceuticals | 2 | $62 |
| Organon | 2 | $53 |
| Orphalan Inc | 2 | $48 |
| Braintree Laboratories, Inc. | 3 | $43 |
| Novo Nordisk | 2 | $42 |
| Ipsen Biopharmaceuticals, Inc | 1 | $32 |
| Boston Scientific | 1 | $24 |
| Amgen | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Tremfya$268
- Rinvoq$249
- Reltone 200 Mg$200
- Reltone 400 Mg$200
- STELARA$127
- IBSRELA$126
- ZEPOSIA$124
- Humira$123
- XIFAXAN$104
How this compares
$6,975 in reported general payments places this provider in the 95th percentile of 1,543 physician assistant providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LinzessLinaclotide | 174 | $106,823 |
| ZenpepLipase/Protease/Amylase | 14 | $33,550 |
| SutabSod Sulf/Pot Chloride/Mag Sulf | 145 | $23,907 |
| TrulancePlecanatide | 25 | $16,509 |
| Mesalamine | 18 | $6,530 |
| Gavilyte-CPeg3350/Sod Sulf,bicarb,cl/Kcl | 215 | $3,612 |
| ClenpiqSod Picosulf/Mag Ox/Citric Ac | 16 | $2,713 |
| Sucralfate | 58 | $2,480 |
| Colestipol Hcl | 21 | $1,710 |
| Omeprazole | 245 | $1,649 |
| CholestyramineCholestyramine (With Sugar) | 29 | $1,580 |
| Famotidine | 139 | $1,088 |
| Esomeprazole Magnesium | 32 | $1,081 |
| Dicyclomine Hcl | 72 | $821 |
| Pantoprazole Sodium | 119 | $706 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLinzess | $1,525 | $106,823174 claims |
| Aimmune Therapeutics, Inc.Zenpep | $245 | $33,55014 claims |
| Braintree Laboratories, Inc.Sutab | $43 | $23,907145 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCTrulance | $956 | $16,50925 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,543 physician assistant providers in Utah.
Other physician assistant in Salt Lake City
- Jill EricksonSalt Lake City$179K
- Natalie BeeSalt Lake City$63K
- Samuel ShewanSalt Lake City$22K
- Christy MaSalt Lake City$17K
- Shane FarrSalt Lake City$14K
- Gintare DaileySalt Lake City$13K
- Corey DahlSalt Lake City$13K
- David JonesSalt Lake City$12K
- Corbin WoodSalt Lake City$12K
- Amy HillierSalt Lake City$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.